Literature DB >> 9140528

Detection of mosquito saliva-specific IgE antibodies by capture ELISA.

H Brummer-Korvenkontio1, K Palosuo, T Palosuo, M Brummer-Korvenkontio, P Leinikki, T Reunala.   

Abstract

We developed an IgE-capture ELISA and measured mosquito saliva-specific IgE antibodies in 27 children sensitive to mosquito bites. Children with large 15-min bite wheals had significantly higher (P < 0.0005) mosquito saliva-specific IgE levels than children with small wheals. In the latter group, the saliva-specific IgE level was significantly higher (P = 0.031) than the levels of six infants never exposed to mosquitoes. A positive correlation (r = 0.65; P = 0.0002) was found between the size of the 15-min wheal and the mosquito saliva-specific IgE antibody levels. These results further support the role of mosquito saliva-specific IgE antibodies in the pathogenesis of mosquito-bite whealing. Compared to immunoblotting, IgE-capture ELISA provides a quantitative method to measure mosquito saliva-specific IgE antibodies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9140528     DOI: 10.1111/j.1398-9995.1997.tb01002.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  9 in total

1.  Human antibody response to Aedes aegypti saliva in an urban population in Bolivia: a new biomarker of exposure to Dengue vector bites.

Authors:  Souleymane Doucoure; François Mouchet; Amandine Cournil; Gilbert Le Goff; Sylvie Cornelie; Yelin Roca; Mabel Guerra Giraldez; Zaira Barja Simon; Roxanna Loayza; Dorothée Misse; Jorge Vargas Flores; Annie Walter; Christophe Rogier; Jean Pierre Herve; Franck Remoue
Journal:  Am J Trop Med Hyg       Date:  2012-07-30       Impact factor: 2.345

2.  First attempt to validate human IgG antibody response to Nterm-34kDa salivary peptide as biomarker for evaluating exposure to Aedes aegypti bites.

Authors:  Emmanuel Elanga Ndille; Souleymane Doucoure; Georgia Damien; François Mouchet; Papa Makhtar Drame; Sylvie Cornelie; Herbert Noukpo; Sandra Yamadjako; Armel Djenontin; Nicolas Moiroux; Dorothee Misse; Martin Akogbeto; Vincent Corbel; Marie-Claire Henry; Fabrice Chandre; Thierry Baldet; Franck Remoue
Journal:  PLoS Negl Trop Dis       Date:  2012-11-15

3.  IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.

Authors:  Papa M Drame; Vanessa Machault; Abdoulaye Diallo; Sylvie Cornélie; Anne Poinsignon; Richard Lalou; Mbacké Sembène; Stéphanie Dos Santos; Christophe Rogier; Frédéric Pagès; Jean-Yves Le Hesran; Franck Remoué
Journal:  Malar J       Date:  2012-03-16       Impact factor: 2.979

Review 4.  Implication of haematophagous arthropod salivary proteins in host-vector interactions.

Authors:  Albin Fontaine; Ibrahima Diouf; Nawal Bakkali; Dorothée Missé; Frédéric Pagès; Thierry Fusai; Christophe Rogier; Lionel Almeras
Journal:  Parasit Vectors       Date:  2011-09-28       Impact factor: 3.876

5.  Evaluation of the human IgG antibody response to Aedes albopictus saliva as a new specific biomarker of exposure to vector bites.

Authors:  Souleymane Doucoure; François Mouchet; Sylvie Cornelie; Jean Sébastien DeHecq; Abdul Hamid Rutee; Yelin Roca; Annie Walter; Jean Pierre Hervé; Dorothée Misse; François Favier; Philippe Gasque; Franck Remoue
Journal:  PLoS Negl Trop Dis       Date:  2012-02-21

6.  Evaluation of the effectiveness of malaria vector control measures in urban settings of Dakar by a specific anopheles salivary biomarker.

Authors:  Papa Makhtar Drame; Abdoulaye Diallo; Anne Poinsignon; Olayide Boussari; Stephanie Dos Santos; Vanessa Machault; Richard Lalou; Sylvie Cornelie; Jean-Yves LeHesran; Franck Remoue
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

Review 7.  Salivary Biomarkers in the Control of Mosquito-Borne Diseases.

Authors:  Souleymane Doucoure; Papa Makhtar Drame
Journal:  Insects       Date:  2015-11-17       Impact factor: 2.769

8.  Human antibody response to Aedes albopictus salivary proteins: a potential biomarker to evaluate the efficacy of vector control in an area of Chikungunya and Dengue Virus transmission.

Authors:  Souleymane Doucoure; François Mouchet; Sylvie Cornelie; Papa Makhtar Drame; Eric D'Ortenzio; Jean Sébastien DeHecq; Franck Remoue
Journal:  Biomed Res Int       Date:  2014-04-13       Impact factor: 3.411

Review 9.  New Immuno-Epidemiological Biomarker of Human Exposure to Aedes Vector Bites: From Concept to Applications.

Authors:  André B Sagna; Mabo C Yobo; Emmanuel Elanga Ndille; Franck Remoue
Journal:  Trop Med Infect Dis       Date:  2018-08-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.